Covid-19 preventive measures @ GVK BIO (Video)

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year. 

Navigating the transition from late pre-clinical stages to commercial success in the biotech and pharmaceutical industries requires a delicate balance between speed and cost efficiency. This session will explore strategic approaches to streamline this critical phase, ensuring timely market entry while controlling cost. It will deep diver into the best practices for managing late-stage development, overcoming regulatory hurdles, and scaling up production. The speaker will share insights on optimizing resource allocation, leveraging innovative technologies, and fostering strategic partnerships to enhance both speed and cost-effectiveness. Attendees will gain actionable strategies to minimize time-to-market and maximize return on investment, ensuring successful commercial launches. Join us to learn how to effectively manage the complexities and sensitivities of advancing from pre-clinical trials to commercial deployment.